Material and methods We analysed DNAmethylation of 1264 genes encoding miRNAs in 26 BCVY samples and 15 samples from BCO using the 'Illumina Infinium MethylationEPIC BeadChip' array. Methylation differences were assessed using Wilcoxon Rank Sum test. Differences observed were validated using two independent populations:Flower et al 2015 and The Genome Caner Atlas (TCGA) methylation datasets. Expression of miRNAs regulated by CpG sites differently methylated were analysed in a meta-analysis using data from ClariomD array, miRNA expression published data from Peña-Chilet et al 2014 and TCGA gene expression data. We perform an expression validation study by real time-PCR of miRNAs differently methylated and expressed in BCVY comparing with older ones. Results and discussions We identified 193 significantly differently methylated CpG sites that were regulating genes encoding miRNAs. The hypomethylated CpGs were localised in islands and regions away from them (opensea) were mainly hypermethylated. We could validate a total of 10 methylation probes regulating miRNAs in the methylation validation data sets. Finally, the miRNAs mir-9-1, mir-184, mir-551b and mir196a-1 were significantly differently methylated and de-regulated in BCVY in comparison with BCO Conclusion We identified a differential miRNA methylation profile in BCVY. Most of the miRNAs differently methylated between breast cancer age groups were previously described with aberrant methylation in cancer. Additionally, some of them presented significant different expression. The present study includes for the first time an analysis of methylation of miRNA encoding genes using the EPICarray in a large cohort of breast cancer samples occurring in young women. The four identified miRNAs with different methylation and expression in BCVY may be a promising epi/genetic biomarkers in BCVY risk.
The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has demonstrated promising efficacy in a variety of hematologic malignancies. However, the precise mechanism of action of the drug remains to be fully elucidated. Tumor-infiltrating macrophages presented in the tumor microenvironment have been shown to promote development and progression of B-cell lymphomas through cross talk mediated by secreted cytokines and chemokines. Because Btk has been implicated in Toll-like receptor (TLR) signaling pathways that regulate macrophage activation and production of proinflammatory cytokines, we investigate the immunomodulatory effects of Btk inhibitor on macrophages.Our results demonstrate that Btk inhibition efficiently suppresses production of CXCL12, CXCL13, CCL19, and VEGF by macrophages.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.